Kestra Medical Technologi... (KMTS)
Company Description
Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company.
It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected.
The company develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.
Its Cardiac Recovery System platform is the ASSURE WCD, a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA).
The company's Cardiac Recovery System platform also includes a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes.
The company was founded in 2014 and is based in Kirkland, Washington.

Country | United States |
IPO Date | Mar 6, 2025 |
Industry | Medical - Instruments & Supplies |
Sector | Healthcare |
Employees | 300 |
CEO | Brian Webster |
Contact Details
Address: 3933 Lake Washington Blvd NE Kirkland, Washington United States | |
Website | https://kestramedical.com |
Stock Details
Ticker Symbol | KMTS |
Exchange | NASDAQ |
Fiscal Year | May - April |
Reporting Currency | USD |
CIK Code | 0001877184 |
CUSIP Number | n/a |
ISIN Number | BMG524411052 |
Employer ID | 00-0000000 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Brian Webster | Founder, President, Chief Executive Officer & Director |
Gordon Teddy | Chief Information Officer |
Vaseem Mahboob | Chief Financial Officer |
Alfred J. Ford Jr. | Chief Commercial Officer |
Debra Schotz | Senior Vice President of Marketing |
Jeffrey Laub | Senior Vice President of Operations |
Neil Bhalodkar | Vice President of Investor Relations |
Phillip D. Foshee Jr. | Senior Vice President of Research & Development |
Traci S. Umberger | Co-Founder, General Counsel, Chief Administrative Officer, Secretary & Director |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 14, 2025 | 8-K | Current Report |
Feb 04, 2025 | DRS/A | [Amend] Filing |
Jan 17, 2025 | DRS/A | [Amend] Filing |
Dec 11, 2024 | DRS/A | [Amend] Filing |
Nov 23, 2021 | DRS/A | [Amend] Filing |
Aug 25, 2021 | DRS | Filing |